Iron-activated molecules show promise against aggressive, treatment-resistant cancer cells

Iron-activated molecules show promise against aggressive, treatment-resistant cancer cells

Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively eliminate specific cancer cells able to adapt to existing treatments and which exhibit high metastatic potential. Yet metastases are responsible for 70% of cancer deaths.

Novel Molecule Inducing Ferroptosis for Metastatic Cancer Therapy

Scientists from Institut Curie, the CNRS, and Inserm have just created a novel class of molecules capable of destroying cancer cells that are resistant to current treatments and cause recurrence.

Until recently, cancer was a death sentence, but today, this disease can be defeated, and this optimism is based on scientific evidence. Spectacular advances in medicine and patients' access to the latest therapies can extend life expectancy or even bring about a cure.

A study published this Wednesday announces the development of molecules capable of causing the death of cancer cells with high metastatic potential, which are responsible for 70% of cancer deaths and current treatments do not effectively eliminate them. - French researchers are developing a class of molecules against metastatic cancers (Health and well-being).